maprotiline has been researched along with Kidney Failure, Chronic in 2 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukunishi, I | 1 |
Kitaoka, T | 1 |
Shirai, T | 1 |
Watanabe, S | 1 |
Kennedy, SH | 1 |
Craven, JL | 1 |
Rodin, GM | 1 |
Roin, GM | 1 |
1 trial available for maprotiline and Kidney Failure, Chronic
Article | Year |
---|---|
Major depression in renal dialysis patients: an open trial of antidepressant therapy.
Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Desipramine; Humans; Kid | 1989 |
1 other study available for maprotiline and Kidney Failure, Chronic
Article | Year |
---|---|
Cardiac arrest caused by maprotiline in an elderly hemodialysis patient.
Topics: Aged; Antidepressive Agents, Tricyclic; Female; Heart Arrest; Humans; Kidney Failure, Chronic; Mapro | 1998 |